Althea completes first shipment of products to Germany

Investment Highlights:

• Althea has completed its first shipment of medicinal cannabis products to Germany
• Initial shipment of 2,000 units valued at approximately $1,000,000 (EUR640,000)
• Althea has partnered with one of the country’s leading pharmaceutical wholesalers of cannabis-based medicines, Nimbus Health GmbH, to launch the brand exclusively in Germany
• Under Althea and Nimbus’ agreement, Althea will receive payment for products supplied to Nimbus, along with 50% of net profit
• The German medicinal cannabis market is the largest medicinal cannabis market in Europe and health insurers typically cover the entire cost of medicinal cannabis treatments

For full ASX announcement – read here